Selected article for: "cell line and transient transfection"

Author: Frenzel, André; Hust, Michael; Schirrmann, Thomas
Title: Expression of Recombinant Antibodies
  • Document date: 2013_7_29
  • ID: 06o7pa3d_46
    Snippet: Recently, transient production of IgG-like scFv-Fc antibodies in the HEK293-6E cell line, a genetically modified variant with a truncated version of EBNA1 growing in suspension and chemically defined serum-free medium (183, 184) , achieved volumetric yields of up to 0.6 g/L by simple shake flask cultivation. Improved production media, fed-batch supplementation, and well-controlled bioreactor processes allow higher cell densities and prolonged pro.....
    Document: Recently, transient production of IgG-like scFv-Fc antibodies in the HEK293-6E cell line, a genetically modified variant with a truncated version of EBNA1 growing in suspension and chemically defined serum-free medium (183, 184) , achieved volumetric yields of up to 0.6 g/L by simple shake flask cultivation. Improved production media, fed-batch supplementation, and well-controlled bioreactor processes allow higher cell densities and prolonged production time, both enhancing the yield. Backliwal and colleagues (177) combined optimized PEI-based transfection at high-cell densities with the coexpression of cell cycle regulators p18 and p21, acidic fibroblast growth factor, valproic acid supplementation, consequent maintenance at high-cell densities of cells/milliliter and up-scaling to 2 L and achieved production levels of more than 1 g IgG within 2 weeks after transient transfection.

    Search related documents:
    Co phrase search for related documents